SGLT-2 Inhibitors for Cardiovascular Outcomes in Heart Failure With Preserved Ejection Fraction

Am Fam Physician. 2023 Jan;107(1):81-82.
No abstract available

MeSH terms

  • Heart
  • Heart Failure*
  • Humans
  • Sodium-Glucose Transporter 2 Inhibitors*
  • Stroke Volume

Substances

  • Sodium-Glucose Transporter 2 Inhibitors